taVNS for Letter Learning in Dyslexia
NCT: NCT06127550 · SUSPENDED
Brief Summary
This is a pilot study to establish feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) for improving letter-learning in adolescents with dyslexia. The main goals of the study are to 1) evaluate whether children in this age range will tolerate low level stimulation over the course of multiple sessions, 2) determine whether low level taVNS improves novel letter learning in dyslexia, and 3) evaluate the effect of low level taVNS on the brain's response to letters. Participants will complete fMRI before training, immediately after training, and a few weeks after training ends. Training will consist of six 30-minute lessons during which participants will learn novel letter-sound relationships while receiving either active or sham taVNS. Researchers will compare stimulation conditions to determine effect of this device on learning and neural plasticity.
Frequently Asked Questions
What is taVNS for Letter Learning in Dyslexia?
taVNS for Letter Learning in Dyslexia is a clinical trial registered under NCT06127550. Current status: SUSPENDED.
What is the status of NCT06127550?
The current status of NCT06127550 (taVNS for Letter Learning in Dyslexia) is: SUSPENDED.
When did taVNS for Letter Learning in Dyslexia start?
taVNS for Letter Learning in Dyslexia started on 2026-09-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.